Truven Health Analytics 10-Q 13 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document	9 Months Ended
	Sep. 30, 2013	Nov. 13, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Truven Holding Corp.	'
Entity Central Index Key	'0001571116	'
Current Fiscal Year End Date	'--12-31	'
Entity Well-known Seasoned Issuer	'No	'
Entity Voluntary Filers	'No	'
Entity Current Reporting Status	'No	'
Entity Filer Category	'Non-accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	1

Interim_Condensed_Consolidated

Interim Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$7,769	$23,805
Trade and other receivables (less allowances of $1,476 and $1,865, respectively)	91,814	105,141
Prepaid expenses and other current assets	22,862	18,409
Deferred tax assets	3,047	10,648
Total current assets	125,492	158,003
Computer hardware and other property, net	43,097	40,191
Developed technology and content, net	150,500	160,335
Goodwill	824,339	824,339
Other identifiable intangible assets, net	370,628	396,473
Other noncurrent assets	16,220	17,786
Total assets	1,530,276	1,597,127
Current liabilities	'	'
Accounts payable and accrued expenses	79,814	92,507
Deferred revenue	112,189	122,319
Current portion of long-term debt	5,350	5,276
Capital lease obligation	946	0
Income taxes payable	372	82
Total current liabilities	198,671	220,184
Deferred revenue	2,069	5,354
Long-term debt	852,525	832,696
Deferred tax liabilities	88,691	118,675
Other noncurrent liabilities	1,590	966
Total liabilities	1,143,546	1,177,875
Equity	'	'
Common stock—$ 0.01 par value; 1,000 shares authorized, 1 share issued and outstanding at September 30, 2013 and December 31, 2012	0	0
Additional paid-in capital	477,829	473,364
Accumulated deficit	-91,080	-54,112
Foreign currency translation adjustment	-19	0
Total equity	386,730	419,252
Total liabilities and equity	$1,530,276	$1,597,127

Interim_Condensed_Consolidated1

Interim Condensed Consolidated Balance Sheets (Unaudited) Parenthetical (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Allowance for doubtful accounts receivables	$1,476	$1,865
Common stock par value (in dollars per share)	$0.01	$0.01
Common stock shares authorized (in shares)	1,000	1,000
Common stock share issued (in shares)	1	1
Common stock shares outstanding (in shares)	1	1

Interim_Condensed_Consolidated2

Interim Condensed Consolidated and Combined Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended	5 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Jun. 06, 2012
					Predecessor
Revenues, net	$123,594	$100,950	$124,263	$363,481	$208,998
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	-64,293	-62,254	-77,072	-200,983	-112,050
Selling and marketing, excluding depreciation and amortization	-12,899	-12,500	-16,249	-42,111	-25,917
General and administrative, excluding depreciation and amortization	-12,387	-9,708	-12,784	-31,326	-27,173
Allocation of costs from Predecessor Parent and affiliates	0	0	0	0	-10,003
Depreciation	-5,422	-2,492	-3,104	-14,411	-6,805
Amortization of developed technology and content	-8,228	-6,425	-8,076	-23,672	-12,460
Amortization of other identifiable intangible assets	-8,615	-8,614	-10,912	-25,845	-8,226
Other operating expenses	-8,278	-10,665	-40,416	-28,778	-18,803
Total operating costs and expenses	-120,122	-112,658	-168,613	-367,126	-221,437
Operating income (loss)	3,472	-11,708	-44,350	-3,645	-12,439
Interest expense	-16,661	-19,431	-24,446	-54,753	0
Interest income	0	0	0	0	3
Unrealized foreign exchange loss	-19	0	0	-472	0
Loss before income taxes	-13,208	-31,139	-68,796	-58,870	-12,436
Benefit from income taxes	4,865	11,054	22,685	21,902	4,803
Net loss	-8,343	-20,085	-46,111	-36,968	-7,633
Other comprehensive loss:	'	'	'	'	'
Foreign currency translation adjustments	-17	0	0	-19	0
Total comprehensive loss	($8,360)	($20,085)	($46,111)	($36,987)	($7,633)

Condensed_Consolidated_and_Com

Condensed Consolidated and Combined Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended	9 Months Ended	5 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2012	Sep. 30, 2013	Jun. 06, 2012
			Predecessor
Operating activities	'	'	'
Net loss	($46,111)	($36,968)	($7,633)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:	'	'	'
Depreciation	3,104	14,411	6,805
Amortization of developed technology and content	8,076	23,672	12,460
Amortization of other identifiable intangible assets	10,912	25,845	8,226
Amortization of debt issuance costs	961	1,931	0
Amortization of debt discount	561	1,922	0
Amortization of unfavorable leasehold interest	-60	-94	0
Loss on extinguishment of debt	0	2,353	0
Deferred income tax (benefit) provision	-22,685	-22,383	543
Share-based compensation expense	0	1,137	2,519
Retention bonus in conjunction with the Acquisition	8,070	1,378	5,800
Changes in operating assets and liabilities:	'	'	'
Trade and other receivables	-16,829	13,328	32,869
Prepaid expenses and other current assets	-1,327	-4,453	388
Accounts payable and accrued expenses	33,522	-7,203	-21,582
Bank overdrafts	0	0	-2,630
Deferred revenue	14,708	-13,415	-19,739
Income taxes	0	289	-514
Other	459	-599	294
Net cash provided by (used in) operating activities	-6,639	1,151	17,806
Investing activities	'	'	'
Acquisitions, net of cash acquired	-1,249,402	0	0
Capital expenditures	-10,924	-34,853	-10,285
Net cash used in investing activities	-1,260,326	-34,853	-10,285
Financing activities	'	'	'
Issuance of common stock	464,400	0	0
Additional capital contribution	0	1,950	0
Proceeds from senior term loan, net of original issue discount	517,125	0	0
Proceeds from senior notes, net of original issue discount	325,007	0	0
Proceeds from revolving credit facility	0	15,000	0
Principal repayment of senior term loan	-1,319	-3,994	0
Proceeds from senior term loan, net of original issue discount	0	86,105	0
Principal repayment of senior term loan related to refinancing	0	-74,772	0
Premium payment for refinancing the credit facility	0	-5,760	0
Payment of debt issuance costs	-21,616	0	0
Payment of capital lease obligation	0	-844	0
Decrease in net investment of Predecessor Parent	0	0	-16,760
Decrease in notes receivable from Predecessor Parent	0	0	9,247
Net cash provided by (used in) financing activities	1,283,597	17,685	-7,513
Effect of exchange rate changes in cash	0	-19	0
Increase (decrease) in cash and cash equivalents	16,632	-16,036	8
Cash and Cash Equivalents	'	'	'
Beginning of period	0	23,805	70
End of period	16,632	7,769	78
Supplemental Cash Flow Information	'	'	'
Interest Paid	$11,323	$38,100	$0

Condensed_Consolidated_Stateme

Condensed Consolidated Statement of Equity (Unaudited) (USD $)	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
In Thousands, unless otherwise specified
Balance at beginning period at Dec. 31, 2012	$419,252	$0	$473,364	($54,112)	$0
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Additional capital contribution	1,950	'	1,950	'	'
Retention bonus in conjunction with the Acquisition	1,378	'	1,378	'	'
Share-based compensation expense	1,137	'	1,137	'	'
Foreign currency translation adjustments	-19	'	'	'	-19
Net loss	-36,968	'	'	-36,968	'
Balance at ending period at Sep. 30, 2013	$386,730	$0	$477,829	($91,080)	($19)

Description_of_Business_and_Ba

Description of Business and Basis of Presentation (Notes)	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Description of Business and Basis of Presentation	'
	Description of Business and Basis of Presentation
	Description of the Business
	On April 23, 2012, VCPH Holding Corp. (now known as Truven Holding Corp., the “Company”), an affiliate of Veritas Capital Fund Management, L.L.C. (“Veritas Capital” or the “Sponsor”), entered into the Stock and Asset Purchase Agreement with Thomson Reuters U.S. Inc. (“TRUSI”) and Thomson Reuters Global Resources (“TRGR”), both affiliates of the Thomson Reuters Corporation (“the Stock and Asset Purchase Agreement”), which VCPH Holding Corp. assigned to Wolverine Healthcare Analytics, Inc. (“Wolverine”) on May 24, 2012. Wolverine is an affiliate of The Veritas Fund IV, L.P., a fund managed by Veritas Capital. Pursuant to the Stock and Asset Purchase Agreement, on June 6, 2012, Wolverine acquired 100% of the equity interests of Thomson Reuters (Healthcare) Inc. (“TRHI”) from TRUSI and certain other assets and liabilities of the Thomson Reuters Healthcare business from TRGR and its affiliates (the “Acquisition”). Upon the closing of the Acquisition, Wolverine merged with and into TRHI, with TRHI surviving the merger (the “Merger”) as a direct wholly-owned subsidiary of the Company, and subsequently changed its name to Truven Health Analytics Inc. (“Truven”). Following the Merger, the assets acquired and liabilities assumed are now held by Truven, which remains a direct wholly-owned owned subsidiary of the Company.
	Truven provides healthcare data and analytics solutions and services to key constituents in the healthcare system, including employers and health plans, federal government agencies, state government agencies, hospitals, clinicians and pharmaceutical companies. Truven operates and manages its business under three reportable segments: Payer, Hospitals and Clinicians.
	Truven Holding Corp. was formed on April 20, 2012, by Veritas Capital for the purpose of consummating the Acquisition and has had no operations from inception other than its investment in Truven.
	Basis of Presentation
	These unaudited interim condensed consolidated and combined financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim reporting and are consistent with the accounting policies and method used in preparation of the Company's consolidated and combined financial statements as of December 31, 2012 and for the 2012 Periods. The preparation of interim condensed consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the interim condensed consolidated and combined financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions that the Company may undertake in the future, actual results could differ from those estimates. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal and recurring adjustments) necessary for a fair statement for the periods presented have been recorded. The results of operations for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2013. These financial statements should be read in conjunction with, and have been prepared in conformity with, the accounting principles reflected in the Company’s financial statements and the notes thereto for the 2012 Periods included in the Amendment No. 1 to Form S-4 as filed with the SEC on June 19, 2013 and declared effective on June 26, 2013 ("Form S-4/A").
	Successor - The accompanying unaudited interim condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012, condensed consolidated statements of comprehensive income (loss) for the three and nine month periods ended September 30, 2013, and statement of equity and cash flows for the nine month period ended September 30, 2013, include the accounts of Truven Holding Corp. from January 1, 2013 to September 30, 2013. The consolidated financial statements of the Successor reflect the Acquisition under the acquisition method of accounting, in accordance with the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 850, Business Combinations.
	Predecessor - The accompanying unaudited interim condensed combined financial statements of the Thomson Reuters Healthcare business (our “Predecessor”) prior to the Acquisition on June 6, 2012, include the unaudited interim condensed combined financial statements of TRHI and certain assets owned by subsidiaries of Thomson Reuters Corporation (“Thomson Reuters” or the “Predecessor Parent”).
	Before the Acquisition, our Predecessor operated as a business unit of Thomson Reuters and not as a standalone company. TRHI was a wholly-owned owned indirect subsidiary of Thomson Reuters, and certain of the company's assets were owned by subsidiaries of Thomson Reuters. During the Predecessor Period, TRHI engaged in extensive intercompany transactions with Thomson Reuters and its subsidiaries related to certain support services, and Thomson Reuters allocated the cost of these services as “Allocation of costs from Predecessor Parent and affiliates” in the condensed combined statement of comprehensive loss (see Note 8). For the Predecessor Period, the accompanying condensed combined financial statements reflect the assets, liabilities, revenues and expenses directly attributed to the Thomson Reuters Healthcare business as well as certain allocations by the Predecessor Parent. All significant transactions in the Predecessor Period between TRHI and other Thomson Reuters entities were included in our Predecessor's condensed combined financial statements. The expense and cost allocations were determined on bases that were deemed reasonable by management in order to reflect the utilization of services provided or the benefit received by TRHI during the periods presented. The combined financial information included herein does not necessarily reflect the results of operations, financial position, changes in equity and cash flows of the Company in the future or what would have been reflected had we operated as a separate, standalone entity during the periods presented. The income tax benefits and provisions, related tax payments and deferred tax balances were prepared as if the Predecessor had operated as a standalone taxpayer for the Predecessor Periods presented.
	Truven Holding Corp. has no operations other than its investment in Truven. Therefore, the unaudited interim condensed consolidated and combined financial statements of Truven Holding Corp. reflect the financial position and results of operations of Truven.
	Reclassification
	In order to conform the prior periods with the current period presentation, the Company has reclassified facilities costs previously recorded in the “General and administrative, excluding depreciation and amortization” to “Costs of revenues, excluding depreciation and amortization” and “Selling and marketing, excluding depreciation and amortization” accounts amounting to $3.3 million and $0.4 million, respectively, in the Predecessor Period from January 1, 2012 to June 6, 2012, $2.5 million and $0.3 million, respectively, in the Successor Period from inception (April 20, 2012) to September 30, 2012, and $2.0 million and $0.2 million respectively, in the Successor Period for the three months ended September 30, 2012. These reclassifications did not have an impact on the Company’s balance sheet and statement of cash flows for the periods presented.
	Revision of Previously Issued Financial Statements
	During the fourth quarter of 2012, the Company identified and recorded adjustments to correct deferred revenues, certain accrued liabilities and related expense accounts. Management performed a review to determine the impact of the adjustments in its previously issued interim financial statements and concluded certain adjustments, while not material (individually or in aggregate), impacted the interim financial statements for the third quarter of 2012. The adjustments have no impact on the Company's balance sheet as of December 31, 2012 or the statements of comprehensive loss and cash flows for the period from January 1, 2012 to June 6, 2012 as presented within our annual financial statements included in our Form S-4/A.
	We have revised our previously issued unaudited condensed consolidated and combined statements of comprehensive loss for the Successor periods ended September 30, 2012 and statement of cash flows for the Successor period ended September 30, 2012, to give effect to the recording of certain revenues and accrual of expenses recorded in the fourth quarter of 2012 that impact the interim financial statements as described above. The interim financial statements were previously distributed to a limited group primarily comprising the holders of our 10.625%% Senior Notes and the financial institutions with participation in our Senior Credit Facility.
	The following table summarizes the effects of the revisions on the Company's unaudited interim condensed statement of consolidated comprehensive loss for three month period ended September 30, 2012, the period from April 20, 2012 to September 30, 2012, and the Company's unaudited condensed statement of consolidated cash flows for the period from April 20, 2012 to September 30, 2012:
	Comprehensive loss for the three month period ended September 30, 2012 (Successor):
		As Reported			Adjustments			As Revised
	Revenues, net	$	104,865		$	(3,915	)	$	100,950
	Total operating costs and expenses	(113,429		)	771			(112,658		)
	Operating loss	(8,564		)	(3,144		)	(11,708		)
	Loss before income taxes	(27,995		)	(3,144		)	(31,139		)
	Benefit from income taxes	9,932			1,122			11,054
	Net loss	(18,063		)	(2,022		)	(20,085		)
	Total comprehensive loss	$	(18,063	)	$	(2,022	)	$	(20,085	)
	Comprehensive loss for the period from April 20, 2012 to September 30, 2012 (Successor):
		As Reported			Adjustments			As Revised
	Revenues, net	$	127,695		$	(3,432	)	$	124,263
	Total operating costs and expenses	(168,161		)	(452		)	(168,613		)
	Operating loss	(40,466		)	(3,884		)	(44,350		)
	Loss before income taxes	(64,912		)	(3,884		)	(68,796		)
	Benefit from income taxes	21,299			1,386			22,685
	Net loss	(43,613		)	(2,498		)	(46,111		)
	Total comprehensive loss	$	(43,613	)	$	(2,498	)	$	(46,111	)
	Cash flow for the period from April 20, 2012 to September 30, 2012 (Successor):
		As Reported			Adjustments			As Revised
	Net cash used in operating activities	$	(1,609	)	$	(5,030	)	$	(6,639	)
	Net cash used in investing activities	(1,264,825		)	4,499			(1,260,326		)

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements (Notes)	9 Months Ended
	Sep. 30, 2013
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In February 2013, the FASB issued Accounting Standards Update No. 2013-02, Comprehensive Income (Topic 220) ("ASU 2013-02"). The amendments in ASU 2013-02 supersede and replace the presentation requirements for reclassifications out of accumulated other comprehensive income in ASU 2011-05 and ASU 2011-12 for all public and private organizations. The amendments would require an entity to provide additional information about reclassifications out of accumulated other comprehensive income. The amendments in ASU 2013-02 are effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2012. The Company adopted ASU 2013-02 effective January 1, 2013. The adoption of this standard has no impact on the Company’s unaudited interim condensed consolidated financial statements.
	In July 2013, the FASB issued ASU 2013-11, Income taxes (Topic 740):Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. The amendment requires an unrecognized tax benefit or portion of an unrecognized tax benefit to be presented as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward except when certain conditions exist. The amendment in ASU 2013-11 is effective for the Company for fiscal years beginning after December 15, 2013, including interim periods in 2014. The adoption of this standard will not impact the Company's financial position, results of operations or cash flows.

Acquisition_Notes

Acquisition (Notes)	9 Months Ended
	Sep. 30, 2013
Business Combinations [Abstract]	'
Acquisition	'
	Acquisition
	On June 6, 2012, as fully described in Note 1, the Company completed the Acquisition of the Thomson Reuters Healthcare business (subsequently renamed Truven Health Analytics Inc. (“Truven”)) from subsidiaries of the Thomson Reuters Corporation for net cash consideration of $1,249,402. The direct costs associated with the Acquisition amounted to $26,734 and were recorded as period costs.
	The Company financed the Acquisition and paid related costs and expenses associated with the Acquisition and the financing as follows: (i) approximately $464,400 in common equity was contributed by entities affiliated with the Sponsor and certain co-investors; (ii) $527,625 principal amount was borrowed under the Term Loan Facility; and (iii) $327,150 aggregated principal amount of Notes (as defined below) were issued.
	On June 6, 2013, the Company finalized the acquisition date fair values of acquired assets and liabilities, including the valuations of identifiable intangible assets, computer hardware and other equipment, and developed technology and content. The determination of fair value of acquired assets involves a variety of assumptions, including estimates associated with useful lives. As discussed in our second quarter unaudited interim condensed and consolidated financial statements, the finalization of these valuations and completion of management review of certain accounts resulted in the refinement of certain assets and liabilities and that resulted in a reduction of $533 to goodwill and a corresponding increase in current asset, noncurrent asset and noncurrent deferred tax liabilities of $458, $120 and $45, respectively, from the previously reported amounts as of December 31, 2012 and March 31, 2013. In accordance with the Company's accounting policy described in Note 2 of the annual financial statements for the year ended December 31, 2012, included in the Form S-4/A, the adjustments on finalization of the purchase accounting were recognized retrospectively to the date of acquisition.
	The following is a summary of the final allocation of the final purchase price of the Acquisition to the estimated fair values of assets acquired and liabilities assumed in the Acquisition. The final allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Final values recognized at acquisition date
	Trade and other receivables	$	77,598
	Prepaid assets and other current assets	11,973
	Computer hardware and other property	24,693
	Developed technology and content	159,622
	Other identifiable intangible assets	416,000
	Other noncurrent assets	106
	Current deferred tax assets	11,262
	Current liabilities	(46,588		)
	Deferred revenue	(80,239		)
	Noncurrent deferred tax liabilities	(149,364		)
	Net assets acquired	425,063
	Goodwill on acquisition	824,339
	Net consideration paid in cash	$	1,249,402
	The following unaudited pro forma financial data summarizes the Company's results of operations for the nine months ended September 30, 2012 and the three months ended September 30, 2012 had the Acquisition occurred on January 1, 2011:
		Nine months ended September 30, 2012			Three months ended September 30, 2012
	Revenues, net	$	361,785		$	122,630
	Net loss	(17,444		)	(1,277		)

Longterm_Debt_Notes

Long-term Debt (Notes)	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Long-Term Debt	'
	Long-Term Debt
	The Company's long-term debt consists of the following:
		September 30, 2013		December 31, 2012
	Senior Credit Facility
	Term Loan Facility (net of $14,810 and $12,174 discount, respectively)	$	517,515	$	512,813
	Revolving Credit Facility	15,000		—
	10.625% Senior Notes ("the Exchange Notes") (net of $1,790 and $1,991 discount, respectively)	325,360		325,159
		857,875		837,972
	Less: current portion of long-term debt	5,350		5,276
	Long-term debt	$	852,525	$	832,696
	In connection with the Acquisition, on June 6, 2012, Truven entered into the Senior Credit Facility and issued the 10.625% Senior Notes in a private offering the ("Old Notes").
	Senior Credit Facility
	The Senior Credit Facility, as amended on April 26, 2013, is with a syndicate of banks and other financial institutions and provides financing of up to $585.0 million, consisting of the $535.0 million Term Loan Facility with a maturity of seven years and the $50.0 million Revolving Credit Facility with a maturity of five years. As of September 30, 2013, the Company has an outstanding revolving loan of $15.0 million and outstanding letters of credit amounting to $0.3 million, which, while not drawn, reduce the available line of credit under the Revolving Credit Facility to $34.7 million.
	Borrowings under the Senior Credit Facility, other than swing line loans, bear interest at a rate per annum equal to an applicable margin plus, at Truven’s option, either (a) a base rate determined by reference to the highest of (1) the prime rate of JPMorgan Chase Bank, N.A., (2) the federal funds effective rate plus 0.50% and (3) the one month Eurodollar rate plus 1.00%; provided, that the base rate for the Term Loan Facility at any time shall not be less than 2.25%, or (b) a Eurodollar rate adjusted for statutory reserve requirements for a one, two, three or six month period (or a nine or twelve month interest period if agreed to by all applicable lenders); provided that the Eurodollar base rate used to calculate the Eurodollar rate for the Term Loan Facility at any time shall not be less than 1.25%. Swing line loans will bear interest at the interest rate applicable to base rate loans, plus an applicable margin. In addition to paying interest on outstanding principal under the Senior Credit Facility, we are required to pay a commitment fee to the lenders under the Revolving Credit Facility in respect of the unutilized commitments thereunder at a rate equal to 0.50% (subject to reduction upon attainment of certain leverage ratios). We will also pay customary letter of credit fees and certain other agency fees. Truven may voluntarily repay outstanding loans under the Senior Credit Facility at any time without premium or penalty, other than customary “breakage” costs with respect to adjusted LIBOR loans. We are required to repay $1.3 million of the Term Loan Facility quarterly, through March 31, 2019, with any remaining balance due June 6, 2019.
	All obligations under the Senior Credit Facility are guaranteed by Truven Holding Corp. and each of Truven’s future wholly-owned domestic subsidiaries (of which there are currently none). All obligations under the Senior Credit Facility and the guarantees of those obligations are collateralized by first priority security interests in substantially all of Truven’s assets as well as those of each guarantor (subject to certain limited exceptions).
	The Senior Credit Facility contains a number of covenants that, among other things, restrict, subject to certain exceptions, Truven’s ability and the ability of each of any restricted subsidiaries to sell assets; incur additional indebtedness; prepay other indebtedness (including the Notes); pay dividends and distributions or repurchase its capital stock; create liens on assets; make investments; make certain acquisitions; engage in mergers or consolidations; engage in certain transactions with affiliates; amend certain charter documents and material agreements governing subordinated indebtedness, change the business conducted by it and its subsidiaries; and enter into agreements that restrict dividends from subsidiaries.
	In addition, the Senior Credit Facility requires Truven, commencing with the fiscal quarter ended June 30, 2012, to comply with a quarterly maximum consolidated senior secured leverage ratio in accordance with the debt covenants as long as the commitments under the Revolving Credit Facility remain outstanding (subject to certain limited exceptions). The Senior Credit Facility also contains certain customary representations and warranties, affirmative covenants and events of default. As of September 30, 2013, the Company is in compliance with all of these credit facility covenants.
	Refinancing
	On October 3, 2012, we entered into the First Amendment to the Senior Credit Facility with a syndicate of banks and other financial institutions with no changes in the terms and conditions other than the reduction of the applicable margin by 1.00%. The loans with certain lenders had been determined to be extinguished under FASB ASC Topics 470-50, Modifications and Extinguishments.
	On April 26, 2013, we entered into the Second Amendment to the Senior Credit Facility (referred to as the "April 2013 Refinancing") with a syndicate of banks and other financial institutions to (i) increase the aggregate principal amount of the Term Loan Facility from $523.7 million to $535.0 million, (ii) reduce the applicable margin by 1.25%, (iii) with respect to the Term Loan Facility, determine the applicable margin in accordance with a pricing grid based on our consolidated total leverage ratio following delivery of financial statements at the end of each fiscal year or quarter, as applicable, after the second quarter of fiscal year 2013, (iv) revise the quarterly principal payments from $1,319.0 to $1,337.5 starting in June 30, 2013 and (v) extend the 1% repricing call protection from June 6, 2013 to October 26, 2013. There were no other changes in the terms and conditions. The loans with certain lenders in the bank syndicate had been determined to be extinguished under FASB ASC Topics 470-50, Modifications and Extinguishments. As a result, the Company recorded a loss on early extinguishment on certain debt amounting to $3.3 million during the period, representing unamortized debt discount, unamortized debt issue costs and certain costs related to the extinguished debt. The loss on early extinguishment of debt is included in interest expense in the unaudited interim condensed consolidated statements of comprehensive loss.
	In connection with the April 2013 Refinancing, the Company incurred lenders' fees of $6.7 million, representing call premium. Of the $6.7 million, $5.8 million was recorded as part of original issue discount and presented as net of debt in the unaudited interim condensed consolidated balance sheet as of September 30, 2013. Other third party costs of $0.1 million, representing legal costs, were recorded as an expense for the nine month period ended September 30, 2013.
	The remaining lenders' fees of $0.9 million related to the debt extinguished has been expensed as part of interest expense in the unaudited interim condensed consolidated statement of comprehensive loss for the nine month period ended September 30, 2013 and is presented under cash flows from operating activities in the Company’s unaudited interim condensed consolidated statement of cash flows for the nine month period ended September 30, 2013.
	10.625% Senior Notes due 2020
	The Notes, which were issued under an indenture, dated June 6, 2012 ( the “Indenture”, as supplemented by the First Supplemental Indenture whereby Truven became a party to the Indenture as successor in interest to Wolverine and the Second Supplemental Indenture referred to below, the “Second Supplemental Indenture”), with The Bank of New York Mellon Trust Company, N.A. as trustee, bear interest at a rate of 10.625% per annum, payable on June 1 and December 1 of each year (commencing on December 1, 2012), and have a maturity date of June 1, 2020.
	The Notes are general unsecured senior obligations of Truven, fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Truven Holding Corp. and each of Truven’s existing and future wholly-owned domestic restricted subsidiaries (of which there currently are none) that is a borrower under or that guarantees the obligations under the Senior Credit Facility or any other indebtedness of Truven or any other guarantor.
	Truven may redeem some or all of the Notes at any time prior to June 1, 2016 at 100% of the principal amount thereof plus the applicable premium pursuant to the Indenture as of the applicable redemption date, plus accrued and unpaid interest and any additional interest to, but excluding, the applicable redemption date. Truven may redeem some or all of the Notes at any time on or after June 1, 2016 at 105.313% of the principal amount thereof, declining ratably to 100% of the principal amount thereof on or after June 1, 2018, plus, in each case, accrued and unpaid interest and any additional interest to, but excluding, the applicable redemption date. In addition, at any time prior to June 1, 2015, Truven (subject to certain conditions) may redeem up to 35% of the aggregate principal amount of the Notes using net cash proceeds from certain equity offerings at 110.625% of the aggregate principal amount of the Notes plus accrued and unpaid interest and any additional interest, to, but excluding, the applicable redemption date. If Truven experiences a change of control (as defined in the Indenture), it will be required to make an offer to repurchase the Notes at a price in cash equal to 101% of the aggregate principal amount thereof, plus accrued and unpaid interest, and any additional interest, to, but excluding, the date of purchase.
	The Indenture contains covenants limiting Truven and its restricted subsidiaries with respect to other indebtedness, investments, liens, dividends, purchases or redemptions of stock, transactions with affiliates and mergers and sales of assets. The Indenture also contains covenants limiting the ability of wholly-owned restricted subsidiaries to guarantee payment of any indebtedness of Truven or any subsidiary guarantor and limiting the Company’s business and operations. We are in compliance with all of these covenants as of September 30, 2013.
	On June 5, 2013, we entered into the second supplemental indenture (the “Second Supplemental Indenture”), whereby the guarantee release provision in Section 10.2(d)(1)(B) of the Indenture, which allows guarantors to be released from their obligations under the Indenture upon the release or discharge of such guarantor’s guarantee of the Senior Credit Facility or the guarantee which resulted in the creation of the guarantee under the Indenture (subject to certain limitations), was amended to apply only to subsidiary guarantors and not to Truven Holding.
	Pursuant to a registration rights agreement dated June 6, 2012, we agreed (i) to use commercially reasonable efforts to file with the SEC an exchange offer registration statement pursuant to which we will exchange the Old Notes (and related guarantees) for a like aggregate principal amount of new registered notes, which are identical in all material respects to the Old Notes, except for certain provisions, among others, relating to additional interest and transfer restrictions (the “Exchange Notes”) (and related guarantees) or (ii) under certain circumstances, to use commercially reasonable efforts to file a shelf registration statement with the SEC with respect to the Old Notes (and related guarantees), in each case by March 3, 2013. We did not file the required registration statement for the Notes by March 3, 2013, and consequently, we were required to pay additional penalty interest of 0.25% per annum for the 90 day period commencing March 4, 2013, and an additional 0.25% with respect to each subsequent 90 day period, in each case until and including the date the exchange offer is completed, up to a maximum increase of 1.00% per annum.
	On June 26, 2013, the exchange offer registration statement was declared effective by the SEC. On July 31, 2013, Truven closed its offer to exchange up to $327,150 aggregate principal amount of its 10.625% Senior Notes, Series B, due 2020 (the “Exchange Notes”), which have been registered under the United States Securities Act of 1933, as amended (the “Securities Act”), for its outstanding 10.625% Senior Notes, Series A, due 2020 (the “Old Notes”) that were originally issued on June 6, 2012, in a transaction exempt from registration under the Securities Act and state securities laws. Truven accepted for exchange all $327,150 aggregate principal amount of the Old Notes tendered. As of August 1, 2013, the interest rate on the new Exchange Notes reverted to 10.625%.
	As of September 30, 2013, we had incurred and accrued additional penalty interest of $318.1 of which $197.6 had been paid.
	As of September 30, 2013, principal maturities of long-term debt for the next five years and thereafter consist of:
	2014	$	5,350
	2015	5,350
	2016	5,350
	2017	5,350
	2018	5,350
	Thereafter	825,775
		$	852,525

Other_Operating_Expenses_Notes

Other Operating Expenses (Notes)	9 Months Ended
	Sep. 30, 2013
Other Income and Expenses [Abstract]	'
Other Operating Expenses	'
	Other Operating Expenses
	The components of other operating expenses include the following:
		Three months		Three months ended September 30,
		ended September 30,
		2013		2012
		Successor
	Severance and retention bonuses	$	348	$	7,592
	Acquisition related costs	7,289		2,448
	Other	641		625
	Total other operating expenses	$	8,278	$	10,665
		Nine months ended September 30,		From inception (April 20, 2012) to September 30,		January 1, 2012 to June 6,
		2013		2012		2012
		Successor				Predecessor
	Disposal related costs	$	—	$	—	$	9,818
	Severance and retention bonuses	3,147		9,704		7,741
	Acquisition related costs	23,683		29,879		—
	Other	1,948		833		1,244
	Total other operating expenses	$	28,778	$	40,416	$	18,803
	Predecessor
	Disposal related costs in the Predecessor Period are primarily comprised of audit services, accounting and consulting services and legal fees related to TRUSI's disposal of the Thomson Reuters Healthcare business. Severance and retention bonuses in the Predecessor Period include severances of employees in connection with the planned disposal of TRHI. Prior to the Acquisition, on March 31, 2012, the Predecessor Parent entered into a retention agreement (the “Retention Agreement”) with key TRHI employees in conjunction with the disposal of the business. Pursuant to the Retention Agreement, the Predecessor Parent agreed to provide for retention and bonus payment to certain employees based on a percentage of salary and targeted transaction price, respectively. The payment was contingent upon the employees continuing services to the buyer after the Acquisition for periods ranging from 90 days to one year. Although the Predecessor Parent retains the legal and contractual obligation to pay the employees, the compensation expense was recorded in the period when the service was performed and was allocated in proportion to the days of service in both Predecessor and Successor Periods. As a result, for the period from April 1, 2012 to June 6, 2012, (Predecessor) TRHI recorded $5.8 million of retention and bonuses expense against Net Investment of Predecessor Parent. The compensation which was paid by Predecessor Parent was deemed an investment contribution.
	Successor
	Acquisition related costs include costs incurred related to technology and other costs in connection with the Company's transition into a standalone business. For the three months ended September 30, 2013, acquisition related costs included $4.7 million of expenses incurred mainly as a result of separating our IT infrastructure from Predecessor Parent, $1.1 million of costs related to the transitional services agreement with Thomson Reuters, and $1.5 million related to consulting and other professional fees. For the nine months ended September 30, 2013, acquisition related costs included $10.8 million of expenses associated with data center migration and separation of infrastructure from Predecessor Parent, $9.3 million of costs related to the transitional services agreement with Thomson Reuters and $3.6 million related to rebranding, and consulting and professional fees. For the three months ended September 30, 2012, acquisition related costs included $2.0 million of costs relating to legal, finance, consulting, and professional fees and $0.4 million of disentanglement costs. For the Successor period from April 20, 2012 to September 30, 2012, acquisition related costs consisted of $12.0 million of transaction fees from Veritas, $17.5 million of direct acquisition costs consisting of legal, finance, consulting and professional fees and $0.4 million of disentanglement costs.
	Severance and retention bonuses primarily relate to the Acquisition of TRHI. As discussed above, prior to the Acquisition, on March 31, 2012, the Predecessor Parent entered into the Retention Agreement with key TRHI employees in conjunction with the disposal of the business. The compensation expense was recorded in the period when the service was performed and was allocated in proportion to the days of service in both Predecessor and Successor Periods. For the three and nine month periods ended September 30, 2013, the three month period ended September 30, 2012 and the period from April 20, 2012 to September 30, 2012, Truven recorded $0, $1.4 million, $6.0 million and $8.1 million of retention and bonus expense, respectively, against Additional Paid In Capital in the Equity section of the condensed consolidated balance sheet. The compensation paid by Predecessor Parent on behalf of Truven was deemed a capital contribution.
	The Sponsor advisory fees are included in other expenses and represent fees paid to the Sponsor under the advisory agreement the Company entered into with the Sponsor in connection with the Acquisition (see Note 8).

Segment_Information_Notes

Segment Information (Notes)	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
Segment Information	'
	Segment Information
	The Company operates and manages its business through three reportable segments: Payer, Hospitals and Clinicians. The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (“CODM”). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The accounting policies for the reportable segments are the same as those for the combined Company. The Company’s operations and customers are based primarily in the United States. Each segment also offers distinct integrated products and services related to data analytics and solution platforms offered to customers or groups of similar customers. Results from operating activities represent the profit earned by each segment without allocation of central administrative revenues and expenses, financial income and expenses and income tax benefit and expense. The Company's segments are as follows:
	Payer
	The Payer segment provides information and solutions to various customer channels, such as employers/health plans, pharmaceutical companies, the federal government, and state governments, to improve the cost and quality of healthcare. These solutions focus on care and risk management, which enhance benefit design, medical cost trend management, disease management, network design and quality management processes in healthcare payer and purchasing organizations.
	Hospitals
	The Hospitals segment provides data, analytics, solutions and value‑added services to healthcare providers. These solutions benchmark customer data and evaluate customers’ performance against peer organizations. Typical benchmarks include costs, operational efficiencies, clinical performance and re-admissions.
	Clinicians
	The Clinicians segment delivers high value content, solutions and sophisticated decision support tools to nurses, physicians and pharmacists. These solutions and tools are aimed at improving patient care, reducing medication errors and enhancing disease and condition management.
	Segment information for the three months ended September 30, 2013 and September 30, 2012 (Successor) is as follows:
		Three months ended September 30, 2013
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	65,286		$	6,819		$	8,824
	Hospitals	31,138			3,885			4,019
	Clinicians	27,170			2,946			7,436
	Segment totals	123,594			13,650			20,279
	Center/Other(2)	—			—			86
		$	123,594		$	13,650		$	20,365
		Three months ended September 30, 2012
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	57,625		$	4,415		$	8,292
	Hospitals	24,642			2,555			480
	Clinicians	18,683			1,947			332
	Segment totals	100,950			8,917			9,104
	Center/Other(2)	—			—			-1,533
		$	100,950		$	8,917		$	7,571
	(1)    Depreciation and amortization expense includes the depreciation of hardware and other tangible assets and the amortization of developed technology and content, but excludes the amortization of other identifiable intangible assets because the CODM during both the Predecessor and Successor Periods did not consider this item when allocating resources and assessing performance.
	(2)    Center/Other costs consist of items that are not directly attributable to reportable segments, such as marketing, technical support, executive, administrative costs and allocations from the Predecessor Parent. Center/Other includes the elimination of intercompany transactions.
	The following table reconciles segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended September 30,			Three months ended September 30,
		2013			2012
		Successor
	Segment operating income	$	20,365		$	7,571
	Amortization of other identifiable intangible assets	(8,615		)	(8,614		)
	Other operating expenses	(8,278		)	(10,665		)
	Operating income (loss)	3,472			(11,708		)
	Interest expense	(16,661		)	(19,431		)
	Unrealized foreign exchange loss	(19		)	—
	Loss before income taxes	$	(13,208	)	$	(31,139	)
	Segment information for the nine months ended September 30, 2013, from inception (April 20, 2012) to September 30, 2012 (Successor), and January 1, 2012 to June 6, 2012 (Predecessor) is as follows:
		Nine months ended September 30, 2013
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	189,904		$	19,161		$	24,366
	Hospitals	92,492			11,024			12,535
	Clinicians	81,085			7,898			22,538
	Segment totals	363,481			38,083			59,439
	Center/Other(2)	—			—			(8,461		)
		$	363,481		$	38,083		$	50,978
		From inception (April 20, 2012) to September 30, 2012
		Successor
		Revenues			Depreciation			Segment
					and			Operating
Amortization(1)					Income
					(Expense)
Payer	$	70,864		$	5,536		$	9,871
Hospitals	31,187			3,203			673
Clinicians	22,212			2,441			-330
Segment totals	124,263			11,180			10,214
Center/Other(2)	—			—			-3,236
	$	124,263		$	11,180		$	6,978
	January 1 to June 6, 2012
	Predecessor
	Revenues			Depreciation			Segment
				and			Operating
				Amortization(1)			Income
							(Expense)
Payer	$	106,482		$	9,539		$	15,411
Hospitals	53,236			5,520			8,222
Clinicians	49,277			4,206			14,347
Segment totals	208,995			19,265			37,980
Center/Other(2)	3			—			(23,390		)
	$	208,998		$	19,265		$	14,590
(1)    Depreciation and amortization expense includes the depreciation of hardware and other tangible assets and the amortization of developed technology and content, but excludes the amortization of other identifiable intangible assets because the CODM during both the Predecessor and Successor Periods did not consider this item when allocating resources and assessing performance.
(2)    Center/Other costs consist of items that are not directly attributable to reportable segments, such as marketing, technical support, executive, administrative costs and allocations from the Predecessor Parent. Center/Other includes the elimination of intercompany transactions.
The following table reconciles segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated and combined statements of comprehensive loss.
	Nine months ended September 30,			From inception (April 20, 2012) to September 30,					January 1, 2012 to June 6,
	2013			2012					2012
	Successor								Predecessor
Segment operating income	$	50,978		$	6,978				$	14,590
Amortization of other identifiable intangible assets	(25,845		)	(10,912		)			(8,226		)
Other operating expenses	(28,778		)	(40,416		)			(18,803		)
Operating loss	(3,645		)	(44,350		)			(12,439		)
Interest income	—			—					3
Interest expense	(54,753		)	(24,446		)			—
Unrealized foreign exchange loss	(472		)	—					—
Loss before income taxes	$	(58,870	)	$	(68,796	)			$	(12,436	)
Reportable segment asset information is not disclosed because it is not reviewed by the CODM for purposes of evaluating performance and allocating resources.

Sharebased_Compensation_Notes

Share-based Compensation (Notes)	9 Months Ended
	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Share-based Compensation	'
	Share-based Compensation
	Share-based compensation expense amounted to $371 and $0 for the three month period ended September 30, 2013 and 2012, respectively.
	Share-based compensation expense amounted to $1,137, $2,519 and $0 for the nine month period ended September 30, 2013, for the period spanning January 1, 2012 to June 6, 2012 and for the period spanning April 20, 2012 to September 30, 2012, respectively.
	Predecessor
	The Predecessor Parent maintained a number of equity-settled share-based compensation awards under which it received services from employees as consideration for equity instruments of the Predecessor Parent. Certain of TRHI’s employees held and participated in the Predecessor Parent’s share-based compensation awards. In connection with the Acquisition, any unvested share-based payments held by TRHI employees became fully vested or had vested on a pro-rata basis in proportion to the performance period that ended at the date of the Acquisition. As of June 6, 2012, all outstanding options held by TRHI employees were exercisable. TRHI employees were given six months from the date of the closing of the Acquisition during which to exercise the options. During the Predecessor period ended June 6, 2012, no options were exercised. Share-based compensation expense amounted $1,870 for the period from April 1, 2012 to June 6, 2012 and $2,519 for the period from January 1, 2012 to June 6, 2012.
	Following the closing of the Acquisition on June 6, 2012, Truven has no share-based payment plan related to the plans administered by our Predecessor.
	Successor
	In October 2012, the Company’s immediate parent, Holdings LLC, established a compensation award in accordance with the Operating Agreement to provide Class B Membership Interests in Holdings LLC to certain executive officers of the Company which shall not exceed 6.25% in the aggregate. The membership interest will vest 20% on each of the first five anniversaries of June 6, 2012, so that 100% of each awardees’ outstanding Class B Membership Interests will vest on June 6, 2017. In addition, 100% of each Class B Membership Interests may vest in certain circumstances in connection with a change in control as defined in the Operating Agreement.
	Each Class B Membership Interest represents the right to receive a percentage of the distribution made by Holdings LLC when such distributions are actually made and such distributions exceed specified internal rates of return thresholds. There are transfer restrictions on the Class B Membership Interests and the executive officers would forfeit the unvested interest upon termination of employment. A summary of the Class B Membership Interests is as follows:
		Ownership interest (%)		Fair value at grant date
	Balance at December 31, 2012	4.1		$	5,714
	Granted	0.6		867
	Forfeited	(0.4	)	(502		)
	Balance at September 30, 2013	4.3		$	6,079
	Outstanding and vested as of September 30, 2013	0.8		$	1,143
	The fair value at the date of grant was based upon the value of the Class B Membership Interests of Holdings LLC less a marketability discount since there is no active market to trade Class B Membership Interests. The marketability discount was determined using a geometric average rate put option model and a Black Scholes put option model using the expected term, risk-free rate, and volatility for liquidity terms. The value was determined as of the grant date based upon a number of factors, including the amount of investment made in exchange for Class B Membership Interests of Holdings LLC by Veritas Capital and certain members of management of the Company.
	The Company recognized compensation expense against additional paid in capital of $371 and $1,137, net of an estimated forfeiture rate of 10%, for the three and nine month periods ended September 30, 2013, respectively, which is recorded in General and administrative expense in the Company’s unaudited interim condensed consolidated statements of comprehensive loss.
	The total unrecognized compensation cost related to nonvested Class B Membership Interest is expected to be recognized over the next 4.5 years is $4,116.
	As of September 30, 2013, 0.8% of Class B Membership Interest has vested with the estimated fair value of $1,185.

Related_Party_Transactions_Not

Related Party Transactions (Notes)	9 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Related Party Transactions
	Predecessor
	Our Predecessor utilized various wholly-owned affiliates of Thomson Reuters to provide administrative services and to finance its operations. In accordance with Securities and Exchange Commission Staff Accounting Bulletin 1-B, “Allocation of Expenses and Related Disclosure in Financial Statements of Subsidiaries, Divisions or Lesser Business Components of Another Entity,” the unaudited interim condensed consolidated and combined financial statements include an allocation of the Predecessor Parent's corporate expenses to our Predecessor, which principally consisted of personnel costs, including salaries, employee benefits and share-based compensation expenses. These costs relate to the corporate executive offices, audit fees, legal services, treasury, communications, human resources, tax services, risk management, technology support, rent and other costs incurred by the Predecessor Parent and its subsidiaries on behalf of our Predecessor. Costs were allocated to the Company based primarily on the proportional revenue. The amounts allocated to the Company for the period ended June 6, 2012, are presented in the unaudited interim condensed combined statement of comprehensive loss as follows:
		Predecessor
		April 1, 2012 to June 6, 2012		January 1, 2012 to June 6, 2012
	Cost of revenues, excluding depreciation and amortization	$	2,254	$	4,868
	Allocation of costs from Predecessor Parent and affiliates	2,550		10,003
		$	4,804	$	14,871
	The allocations included within “Cost of revenues, excluding depreciation and amortization” comprised technology support administered by the Predecessor Parent related to customer data. Allocations were generally computed based on usage metrics.
	The Company believes the assumptions and methodologies underlying the allocations of general corporate overhead from Predecessor Parent were reasonable. However, such expenses may not be indicative of the actual expenses that would have been or will be incurred by TRHI or Truven operating as an independent company. As a result, the financial information herein may not necessarily reflect the combined financial position, results of operations and cash flows of the Company in the future or what it would have been if TRHI or Truven had been an independent company during the periods presented.
	If TRHI or Truven had operated independently of the Predecessor Parent, it is possible that the terms and conditions of these related party transactions, and the resulting amounts recorded, would have been different from those presented in these unaudited interim condensed consolidated and combined financial statements.
	Immediately prior to the Acquisition, a related legal entity, Thomson Reuters Applications, Inc. ("TR Apps"), legally transferred certain fixed assets to TRHI for consideration of $15,975, which was settled via our net intercompany position.  Pursuant to the applicable tax law, while TRHI and TR Apps are part of the same consolidated tax return, no gain/loss or step-up in tax basis was recognized at the time of transfer.  At the close of the Acquisition on June 6, 2012, TRHI ceased to be part of the consolidated tax return group, which resulted in a step up in tax basis for the TR Apps assets.
	Successor
	The Company entered into an advisory agreement with the Sponsor, under which the Sponsor provided certain advisory services to the Company. As compensation for the services, the Company paid a transaction fee at the closing of the Acquisition and will continue to pay the Sponsor an annual advisory fee which will be equal to an aggregate amount equal to the greater of (i) $2.5 million and (ii) 2.0% of consolidated EBITDA (as defined in the credit agreement governing our Senior Credit Facility), as well as transaction fees on future acquisitions, divestitures, financings and liquidity events, which will be determined based upon aggregate equity investments at the time of such future events or on the value of the transaction. For the three and nine month periods ended September 30, 2013, the three month period ended September 30, 2012 and the period from April 20, 2012 to September 30, 2012, the Company recorded an expense of $0.6 million, $1.9 million, $0.6 million, $0.8 million, respectively, which represented the Sponsor advisory fee and is presented within other operating expenses in the Company's unaudited interim condensed consolidated statements of comprehensive loss. As of September 30, 2013, there was no accounts payable to the Sponsor included in the accounts payable and accrued expenses account.
	After the Acquisition, the Company continued to receive certain administrative services (including facilities management, human resource management, finance and accounting operations, treasury, sourcing and procurement and IT services, among other services necessary for the conduct of the business) from Thomson Reuters under the terms of the Transitional Services Agreement. Such services are reflected as third-party activity in the Successor's financial statements. As of September 30, 2013, we have substantially completed our administrative infrastructure, and most of these functions have been assumed by us or by third parties on our behalf including the hosting services of certain technology infrastructure. The expense incurred under this service agreement for the three and nine month periods ended September 30, 2013, the three month period ended September 30, 2012 and the period from April 20, 2012 to September 30, 2012, totaled $0.6 million, $9.9 million, $5.3 million and $6.7 million, respectively, which is included in the other operating expenses in the unaudited interim condensed consolidated statements of comprehensive loss.
	The Company also entered into a reverse transitional services agreement with TRUSI pursuant to which we provide TRUSI with office space and facilities management services at several locations in the United States. Pursuant to the agreement, we will provide these services for certain pre-determined periods ranging from one year to approximately 22 months, with all such services to end by March 31, 2014. The Company is entitled to fees for each of the services provided for any services requested by the Stock Seller. The income recognized under this service agreement for the three and nine month periods ended September 30, 2013, the three month period ended September 30, 2012 and the period from April 20, 2012 to September 30, 2012, totaled of $0.1 million, $0.6 million, $0.2 million and $0.3 million, respectively, which is recorded as a reduction to general and administrative expense in the Company's unaudited interim condensed consolidated and combined statement of comprehensive loss.
	During the first quarter of 2013, Truven Holding Corp. received $1,950 of additional capital contribution from VCPH Holdings LLC, its direct parent company.

Income_Taxes_Notes

Income Taxes (Notes)	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	In the Predecessor period, income tax provisions for the interim period are based on annual estimated tax rates as if the businesses were standalone entities and filed separate income tax returns.
	Following the Acquisition, income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company’s intention is to permanently reinvest its foreign earnings outside of the United States. As a result, the effective tax rates in the periods presented are largely based upon the projected annual pre-tax earnings by jurisdiction and the allocation of certain expenses in various taxing jurisdictions where the Company conducts its business. These taxing jurisdictions apply a broad range of statutory income tax rates.
	Income tax benefit (expense) for the three and nine month periods ended September 30, 2013, the three month period ended September 30, 2012, the period from April 20, 2012 to September 30, 2012, and the period from January 1, 2012 to June 6, 2012 had an effective tax rate of 36.8%, 37.2%, 35.5%, 33.0%, and 38.6%, respectively, and is different from the amount derived by applying the federal statutory tax rate of 35%, mainly due to the impact of certain state income taxes and non deductible expenses. The Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes of multiple states and foreign jurisdictions.

Commitment_and_Contingencies_N

Commitment and Contingencies (Notes)	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitment and Contingencies
	Leases
	Operating Leases
	The Company occupies certain facilities and uses operating equipment under noncancelable operating lease arrangements expiring at various dates through 2021. Future minimum lease payments under these leases are as follows:
	For the period ending September 30,
	2014	$	10,002
	2015	9,778
	2016	9,054
	2017	5,896
	2018	4,091
	Thereafter	7,923
		$	46,744
	Rent expense was $3.1 million and $8.5 million for the three and nine months ended September 30, 2013, respectively. Rent expense was $2.6 million, $3.3 million, and $4.2 million for the three months ended September 30, 2012, for the period from April 20, 2012 to September 30, 2012 and for the period from January 1, 2012 to June 6, 2012, respectively.
	Capital Leases
	In March 2013, the Company entered into a computer hardware lease arrangement that is classified as a capital lease. The net book value of the computer hardware classified as capital leases included in the computer hardware and other property account in the balance sheet amounted to $1.5 million, net of accumulated depreciation of $0.3 million.
	As of September 30, 2013, the future minimum lease payments under capital leases which are payable within a one year period amounted to $972. The present value of net minimum payments excluding the amount representing interest amounted to $946.
	Security and Guarantee Agreements
	The Company has entered into guarantee and security arrangements in respect of its indebtedness as described in Note 4.
	Contractual Commitments
	Revenue Sharing Agreement
	Effective January 1, 2013, the Company modified its agreement with a supplier under which it markets and licenses to its customers a private label version of the supplier's platform solution in conjunction with the Company's health information applications. The agreement contains a revenue share arrangement based on net revenue targets. The supplier's revenue share percentage is guaranteed by the Company in the minimum amounts of $2 million, $4 million and $6 million, for the calendar years 2013, 2014 and 2015, respectively. The guaranteed revenue share is paid in advance by the Company on March 1st of each calendar year and is applied against the revenue share of the supplier earned through March 1st of the following calendar year. The agreement provides a grace period for the Company of up to August 31st of the following calendar year in the event that the supplier's revenue share earned does not reach the prepayment amount. After the grace period, if the revenue share earned does not meet the target then the entire prepayment amount is deemed earned by the supplier. As of September 30, 2013, the balance remaining amounted to $2 million that was paid in 2013.
	Litigation and Legal Proceedings
	Truven has been named as a defendant in approximately 225 separate pharmaceutical tort lawsuits relating to the use of Reglan or its generic version, the first of which was filed in June 2010 and the rest of which were filed in March 2012. All of these actions are pending in the Court of Common Pleas in Philadelphia County, Pennsylvania. In these matters, the plaintiffs complain that they sustained various injuries (including neurological disorders) as a result of their ingestion of Reglan. While a host of drug manufacturers and pharmacies are named as defendants in each of the suits, claims have also been asserted against so-called “Patient Education Monograph” (“PEM”) defendants, including us. It is generally alleged in all of the actions that certain PEM defendants provided Reglan patient drug information to pharmacies which, in turn, provided that drug information to the pharmacies' customers, the plaintiffs in these actions. Plaintiffs further allege that the PEM defendants' patient drug information did not provide adequate warning information about the use of Reglan. Other PEM defendants have also been named in these and other similar actions. In general, the lawsuits have been procedurally consolidated in Philadelphia as mass tort actions. To date, none of the actions against Truven specifically identifies Truven as the author of a PEM that was supplied to a plaintiff. Instead, plaintiffs in these cases allege only that they read an unnamed PEM and, in effect, that it must have been published by at least one of the PEM defendants named in the action.
	Along with other PEM defendants, Truven made one dispositive motion to dismiss all the actions. While that motion to dismiss has been denied, it was without prejudice, permitting Truven to renew at a later stage in the litigation.
	All of these actions were stayed pending the resolution of an appeal by the co-defendant generic drug company defendants; while the appeal was decided against the generic drug companies, this decision will not affect the continuation of the actions against us. At this time, management believes that Truven has meritorious defenses to the claims in each of these actions.
	The Company is also a party to certain legal proceedings arising from the normal course of its operations. Related reserves are recorded when it is probable that liabilities exist and where reasonable estimates of such liabilities can be made. While it is not possible to predict the outcome of any of these proceedings, the Company's management, based on its assessment of the facts and circumstances now known, does not believe that any of these proceedings, individually or in the aggregate, will have a material adverse effect on the Company's financial position, results of operations and cash flows.

Fair_Value_Measurement_Notes

Fair Value Measurement (Notes)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurement	'
	Fair Value Measurement
	Fair value is defined under the Fair Value Measurements and Disclosures Topic of the Codification, FASB ASC 820, as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under FASB ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard established a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:
	• Level 1—Quoted prices in active markets for identical assets or liabilities. These are typically obtained from real-time quotes for transactions in active exchange markets involving identical assets.
	• Level 2—Inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. These are typically obtained from readily-available pricing sources for comparable instruments.
	• Level 3—Unobservable inputs, where there is little or no market activity for the asset or liability. These inputs reflect the reporting entity’s own assumptions of the data that market participants would use in pricing the asset or liability, based on the best information available in the circumstances.
	For purposes of financial reporting, the Company has determined that the fair value of financial instruments including accounts receivable and accounts payable approximates carrying value at September 30, 2013 and December 31, 2012.
	At September 30, 2013, the carrying amounts and fair values of the Senior Credit Facility, revolver and 10.625% Senior Notes were as follows:
				Fair values
		Carrying amounts		Level 1		Level 2		Level 3
	Senior Term Loan	$	517,515	$	—	$	533,656	$	—
	Revolver	15,000		—		15,000		—
	10.625% Senior Notes	325,360		—		361,501		—
	At December 31, 2012, the carrying amounts and fair values of the Senior Credit and 10.625% Senior Notes were as follows:
				Fair values
		Carrying amounts		Level 1		Level 2		Level 3
	Senior Term Loan	$	512,813	$	—	$	528,242	$	—
	10.625% Senior Notes	325,159		—		348,415		—
	Our level 2 inputs are determined based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves.

Subsequent_Events_Notes

Subsequent Events (Notes)	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Events
	In November 2013, a technology vendor verbally indicated that certain license fees relating to technology used in our business may not have been paid by us to the vendor following completion of the Acquisition. To date, the vendor has not quantified the amount of the fees that it believes may be due and we have not received other supporting information from the vendor. We are scheduled to have a further discussion with the vendor concerning this matter during the fourth quarter of the current fiscal year. While the Company could be liable to the vendor in connection with this matter, based on the preliminary nature of the communications to date, we are unable to estimate the amount of such contingent liability, if any, at this time.
	There have been no other events subsequent to September 30, 2013, which would require accrual or disclosure in these unaudited interim condensed consolidated and combined financial statements.

Supplemental_Guarantor_Financi

Supplemental Guarantor Financial Information (Notes)	9 Months Ended
	Sep. 30, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]	'
Unaudited supplemental guarantor financial information	'
	Unaudited Supplemental Guarantor Financial Information
	In connection with the Acquisition, Truven issued the Notes as further described in Note 4. The Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Truven Holding Corp. and each of Truven’s existing and future wholly-owned domestic restricted subsidiaries (of which there currently are none) that is a borrower under or that guarantees the obligations under the Senior Credit Facility or any other indebtedness of Truven or any other guarantor. All obligations under the Senior Credit Facility are also guaranteed by Truven Holding Corp. and each of Truven’s wholly-owned domestic subsidiaries (of which there are currently none). All obligations under the Senior Credit Facility and the guarantees of those obligations are secured by first priority security interests in substantially all of Truven’s assets, as well as those of each guarantor (subject to certain limited exceptions).
	The separate financial statements and the condensed consolidating and combining financial information about the results of operations, financial position and cash flows of the Parent, the Issuer , the Guarantors, the non-Guarantors, and eliminations are not presented due to the following:
	•	Truven (the Issuer) is 100% owned by Truven Holding Corp. (the parent company guarantor)
	•	The Guarantee is full and unconditional and there are no subsidiary guarantors
	•	Truven Holding Corp. has no independent assets or operations.
	•	The transaction costs related to the Acquisition of $26,734 were incurred and paid for by Wolverine, which was merged with and into TRHI, with TRHI surviving the Merger upon closing of the Acquisition as a 100% owned direct subsidiary of Truven Holding Corp. and subsequently changed its name to Truven Health Analytics Inc.
	•	The subsidiaries of Truven Holding Corp. other than Truven, which were newly formed in the fourth quarter of 2012, are minor (as defined in Section 3-10(h)(6) of Regulation S-X of the Securities Act), having total assets, stockholders’ equity, revenues, operating income (before income taxes) and cash flows from operating activities of less than 3% of the Company’s corresponding consolidated amounts.

Description_of_Business_and_Ba1

Description of Business and Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	These unaudited interim condensed consolidated and combined financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim reporting and are consistent with the accounting policies and method used in preparation of the Company's consolidated and combined financial statements as of December 31, 2012 and for the 2012 Periods. The preparation of interim condensed consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the interim condensed consolidated and combined financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions that the Company may undertake in the future, actual results could differ from those estimates. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal and recurring adjustments) necessary for a fair statement for the periods presented have been recorded. The results of operations for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2013. These financial statements should be read in conjunction with, and have been prepared in conformity with, the accounting principles reflected in the Company’s financial statements and the notes thereto for the 2012 Periods included in the Amendment No. 1 to Form S-4 as filed with the SEC on June 19, 2013 and declared effective on June 26, 2013 ("Form S-4/A").
	Successor - The accompanying unaudited interim condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012, condensed consolidated statements of comprehensive income (loss) for the three and nine month periods ended September 30, 2013, and statement of equity and cash flows for the nine month period ended September 30, 2013, include the accounts of Truven Holding Corp. from January 1, 2013 to September 30, 2013. The consolidated financial statements of the Successor reflect the Acquisition under the acquisition method of accounting, in accordance with the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 850, Business Combinations.
	Predecessor - The accompanying unaudited interim condensed combined financial statements of the Thomson Reuters Healthcare business (our “Predecessor”) prior to the Acquisition on June 6, 2012, include the unaudited interim condensed combined financial statements of TRHI and certain assets owned by subsidiaries of Thomson Reuters Corporation (“Thomson Reuters” or the “Predecessor Parent”).
	Before the Acquisition, our Predecessor operated as a business unit of Thomson Reuters and not as a standalone company. TRHI was a wholly-owned owned indirect subsidiary of Thomson Reuters, and certain of the company's assets were owned by subsidiaries of Thomson Reuters. During the Predecessor Period, TRHI engaged in extensive intercompany transactions with Thomson Reuters and its subsidiaries related to certain support services, and Thomson Reuters allocated the cost of these services as “Allocation of costs from Predecessor Parent and affiliates” in the condensed combined statement of comprehensive loss (see Note 8). For the Predecessor Period, the accompanying condensed combined financial statements reflect the assets, liabilities, revenues and expenses directly attributed to the Thomson Reuters Healthcare business as well as certain allocations by the Predecessor Parent. All significant transactions in the Predecessor Period between TRHI and other Thomson Reuters entities were included in our Predecessor's condensed combined financial statements. The expense and cost allocations were determined on bases that were deemed reasonable by management in order to reflect the utilization of services provided or the benefit received by TRHI during the periods presented. The combined financial information included herein does not necessarily reflect the results of operations, financial position, changes in equity and cash flows of the Company in the future or what would have been reflected had we operated as a separate, standalone entity during the periods presented. The income tax benefits and provisions, related tax payments and deferred tax balances were prepared as if the Predecessor had operated as a standalone taxpayer for the Predecessor Periods presented.
	Truven Holding Corp. has no operations other than its investment in Truven. Therefore, the unaudited interim condensed consolidated and combined financial statements of Truven Holding Corp. reflect the financial position and results of operations of Truven.
Segment Information	'
	Segment Information
	The Company operates and manages its business through three reportable segments: Payer, Hospitals and Clinicians. The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (“CODM”). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The accounting policies for the reportable segments are the same as those for the combined Company. The Company’s operations and customers are based primarily in the United States. Each segment also offers distinct integrated products and services related to data analytics and solution platforms offered to customers or groups of similar customers. Results from operating activities represent the profit earned by each segment without allocation of central administrative revenues and expenses, financial income and expenses and income tax benefit and expense. The Company's segments are as follows:
	Payer
	The Payer segment provides information and solutions to various customer channels, such as employers/health plans, pharmaceutical companies, the federal government, and state governments, to improve the cost and quality of healthcare. These solutions focus on care and risk management, which enhance benefit design, medical cost trend management, disease management, network design and quality management processes in healthcare payer and purchasing organizations.
	Hospitals
	The Hospitals segment provides data, analytics, solutions and value‑added services to healthcare providers. These solutions benchmark customer data and evaluate customers’ performance against peer organizations. Typical benchmarks include costs, operational efficiencies, clinical performance and re-admissions.
	Clinicians
	The Clinicians segment delivers high value content, solutions and sophisticated decision support tools to nurses, physicians and pharmacists. These solutions and tools are aimed at improving patient care, reducing medication errors and enhancing disease and condition management.
Income Taxes	'
	Income Taxes
	In the Predecessor period, income tax provisions for the interim period are based on annual estimated tax rates as if the businesses were standalone entities and filed separate income tax returns.
	Following the Acquisition, income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company’s intention is to permanently reinvest its foreign earnings outside of the United States. As a result, the effective tax rates in the periods presented are largely based upon the projected annual pre-tax earnings by jurisdiction and the allocation of certain expenses in various taxing jurisdictions where the Company conducts its business. These taxing jurisdictions apply a broad range of statutory income tax rates.

Description_of_Business_and_Ba2

Description of Business and Basis of Presentation (Tables)	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Schedule of the Revisions on the Company's Statement of Comprehensive Income (Loss)	'
	Comprehensive loss for the three month period ended September 30, 2012 (Successor):
		As Reported			Adjustments			As Revised
	Revenues, net	$	104,865		$	(3,915	)	$	100,950
	Total operating costs and expenses	(113,429		)	771			(112,658		)
	Operating loss	(8,564		)	(3,144		)	(11,708		)
	Loss before income taxes	(27,995		)	(3,144		)	(31,139		)
	Benefit from income taxes	9,932			1,122			11,054
	Net loss	(18,063		)	(2,022		)	(20,085		)
	Total comprehensive loss	$	(18,063	)	$	(2,022	)	$	(20,085	)
	Comprehensive loss for the period from April 20, 2012 to September 30, 2012 (Successor):
		As Reported			Adjustments			As Revised
	Revenues, net	$	127,695		$	(3,432	)	$	124,263
	Total operating costs and expenses	(168,161		)	(452		)	(168,613		)
	Operating loss	(40,466		)	(3,884		)	(44,350		)
	Loss before income taxes	(64,912		)	(3,884		)	(68,796		)
	Benefit from income taxes	21,299			1,386			22,685
	Net loss	(43,613		)	(2,498		)	(46,111		)
	Total comprehensive loss	$	(43,613	)	$	(2,498	)	$	(46,111	)
Schedule of the Revisions on the Company's Statement of Cash Flows	'
	Cash flow for the period from April 20, 2012 to September 30, 2012 (Successor):
		As Reported			Adjustments			As Revised
	Net cash used in operating activities	$	(1,609	)	$	(5,030	)	$	(6,639	)
	Net cash used in investing activities	(1,264,825		)	4,499			(1,260,326		)

Acquisition_Tables

Acquisition (Tables)	9 Months Ended
	Sep. 30, 2013
Business Combinations [Abstract]	'
Allocation of the Purchase Price	'
	The following is a summary of the final allocation of the final purchase price of the Acquisition to the estimated fair values of assets acquired and liabilities assumed in the Acquisition. The final allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Final values recognized at acquisition date
	Trade and other receivables	$	77,598
	Prepaid assets and other current assets	11,973
	Computer hardware and other property	24,693
	Developed technology and content	159,622
	Other identifiable intangible assets	416,000
	Other noncurrent assets	106
	Current deferred tax assets	11,262
	Current liabilities	(46,588		)
	Deferred revenue	(80,239		)
	Noncurrent deferred tax liabilities	(149,364		)
	Net assets acquired	425,063
	Goodwill on acquisition	824,339
	Net consideration paid in cash	$	1,249,402
Unaudited Pro Forma Financial Data	'
	The following unaudited pro forma financial data summarizes the Company's results of operations for the nine months ended September 30, 2012 and the three months ended September 30, 2012 had the Acquisition occurred on January 1, 2011:
		Nine months ended September 30, 2012			Three months ended September 30, 2012
	Revenues, net	$	361,785		$	122,630
	Net loss	(17,444		)	(1,277		)

Longterm_Debt_Tables

Long-term Debt (Tables)	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt Instruments	'
	The Company's long-term debt consists of the following:
		September 30, 2013		December 31, 2012
	Senior Credit Facility
	Term Loan Facility (net of $14,810 and $12,174 discount, respectively)	$	517,515	$	512,813
	Revolving Credit Facility	15,000		—
	10.625% Senior Notes ("the Exchange Notes") (net of $1,790 and $1,991 discount, respectively)	325,360		325,159
		857,875		837,972
	Less: current portion of long-term debt	5,350		5,276
	Long-term debt	$	852,525	$	832,696
Schedule of Principal Maturities of Long-term Debt	'
	As of September 30, 2013, principal maturities of long-term debt for the next five years and thereafter consist of:
	2014	$	5,350
	2015	5,350
	2016	5,350
	2017	5,350
	2018	5,350
	Thereafter	825,775
		$	852,525

Other_Operating_Expenses_Table

Other Operating Expenses (Tables)	9 Months Ended
	Sep. 30, 2013
Other Income and Expenses [Abstract]	'
Components of other operating expenses	'
	The components of other operating expenses include the following:
		Three months		Three months ended September 30,
		ended September 30,
		2013		2012
		Successor
	Severance and retention bonuses	$	348	$	7,592
	Acquisition related costs	7,289		2,448
	Other	641		625
	Total other operating expenses	$	8,278	$	10,665
		Nine months ended September 30,		From inception (April 20, 2012) to September 30,		January 1, 2012 to June 6,
		2013		2012		2012
		Successor				Predecessor
	Disposal related costs	$	—	$	—	$	9,818
	Severance and retention bonuses	3,147		9,704		7,741
	Acquisition related costs	23,683		29,879		—
	Other	1,948		833		1,244
	Total other operating expenses	$	28,778	$	40,416	$	18,803

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information	'
	Segment information for the nine months ended September 30, 2013, from inception (April 20, 2012) to September 30, 2012 (Successor), and January 1, 2012 to June 6, 2012 (Predecessor) is as follows:
		Nine months ended September 30, 2013
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	189,904		$	19,161		$	24,366
	Hospitals	92,492			11,024			12,535
	Clinicians	81,085			7,898			22,538
	Segment totals	363,481			38,083			59,439
	Center/Other(2)	—			—			(8,461		)
		$	363,481		$	38,083		$	50,978
		From inception (April 20, 2012) to September 30, 2012
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	70,864		$	5,536		$	9,871
	Hospitals	31,187			3,203			673
	Clinicians	22,212			2,441			-330
	Segment totals	124,263			11,180			10,214
	Center/Other(2)	—			—			-3,236
		$	124,263		$	11,180		$	6,978
		January 1 to June 6, 2012
		Predecessor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	106,482		$	9,539		$	15,411
	Hospitals	53,236			5,520			8,222
	Clinicians	49,277			4,206			14,347
	Segment totals	208,995			19,265			37,980
	Center/Other(2)	3			—			(23,390		)
		$	208,998		$	19,265		$	14,590
	(1)    Depreciation and amortization expense includes the depreciation of hardware and other tangible assets and the amortization of developed technology and content, but excludes the amortization of other identifiable intangible assets because the CODM during both the Predecessor and Successor Periods did not consider this item when allocating resources and assessing performance.
	(2)    Center/Other costs consist of items that are not directly attributable to reportable segments, such as marketing, technical support, executive, administrative costs and allocations from the Predecessor Parent. Center/Other includes the elimination of intercompany transactions.
	Segment information for the three months ended September 30, 2013 and September 30, 2012 (Successor) is as follows:
		Three months ended September 30, 2013
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	65,286		$	6,819		$	8,824
	Hospitals	31,138			3,885			4,019
	Clinicians	27,170			2,946			7,436
	Segment totals	123,594			13,650			20,279
	Center/Other(2)	—			—			86
		$	123,594		$	13,650		$	20,365
		Three months ended September 30, 2012
		Successor
		Revenues			Depreciation			Segment
					and			Operating
					Amortization(1)			Income
								(Expense)
	Payer	$	57,625		$	4,415		$	8,292
	Hospitals	24,642			2,555			480
	Clinicians	18,683			1,947			332
	Segment totals	100,950			8,917			9,104
	Center/Other(2)	—			—			-1,533
	$	100,950		$	8,917		$	7,571
(1)    Depreciation and amortization expense includes the depreciation of hardware and other tangible assets and the amortization of developed technology and content, but excludes the amortization of other identifiable intangible assets because the CODM during both the Predecessor and Successor Periods did not consider this item when allocating resources and assessing performance.
(2)    Center/Other costs consist of items that are not directly attributable to reportable segments, such as marketing, technical support, executive, administrative costs and allocations from the Predecessor Parent. Center/Other includes the elimination of intercompany transactions.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated	'
	The following table reconciles segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated and combined statements of comprehensive loss.
		Nine months ended September 30,			From inception (April 20, 2012) to September 30,					January 1, 2012 to June 6,
		2013			2012					2012
		Successor								Predecessor
	Segment operating income	$	50,978		$	6,978				$	14,590
	Amortization of other identifiable intangible assets	(25,845		)	(10,912		)			(8,226		)
	Other operating expenses	(28,778		)	(40,416		)			(18,803		)
	Operating loss	(3,645		)	(44,350		)			(12,439		)
	Interest income	—			—					3
	Interest expense	(54,753		)	(24,446		)			—
	Unrealized foreign exchange loss	(472		)	—					—
	Loss before income taxes	$	(58,870	)	$	(68,796	)			$	(12,436	)
	The following table reconciles segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended September 30,			Three months ended September 30,
		2013			2012
		Successor
	Segment operating income	$	20,365		$	7,571
	Amortization of other identifiable intangible assets	(8,615		)	(8,614		)
	Other operating expenses	(8,278		)	(10,665		)
	Operating income (loss)	3,472			(11,708		)
	Interest expense	(16,661		)	(19,431		)
	Unrealized foreign exchange loss	(19		)	—
	Loss before income taxes	$	(13,208	)	$	(31,139	)

Sharebased_Compensation_Tables

Share-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Transaction Related to Class B membership Interest	'
	Class B Membership Interests is as follows:
		Ownership interest (%)		Fair value at grant date
	Balance at December 31, 2012	4.1		$	5,714
	Granted	0.6		867
	Forfeited	(0.4	)	(502		)
	Balance at September 30, 2013	4.3		$	6,079
	Outstanding and vested as of September 30, 2013	0.8		$	1,143

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Costs allocations to the Company from Predecessor	'
	The amounts allocated to the Company for the period ended June 6, 2012, are presented in the unaudited interim condensed combined statement of comprehensive loss as follows:
		Predecessor
		April 1, 2012 to June 6, 2012		January 1, 2012 to June 6, 2012
	Cost of revenues, excluding depreciation and amortization	$	2,254	$	4,868
	Allocation of costs from Predecessor Parent and affiliates	2,550		10,003
		$	4,804	$	14,871

Commitment_and_Contingencies_T

Commitment and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases	'
	Future minimum lease payments under these leases are as follows:
	For the period ending September 30,
	2014	$	10,002
	2015	9,778
	2016	9,054
	2017	5,896
	2018	4,091
	Thereafter	7,923
		$	46,744

Fair_Value_Measurement_Tables

Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Carrying amounts and fair values of the Term Loan Facility	'
	At September 30, 2013, the carrying amounts and fair values of the Senior Credit Facility, revolver and 10.625% Senior Notes were as follows:
				Fair values
		Carrying amounts		Level 1		Level 2		Level 3
	Senior Term Loan	$	517,515	$	—	$	533,656	$	—
	Revolver	15,000		—		15,000		—
	10.625% Senior Notes	325,360		—		361,501		—
	At December 31, 2012, the carrying amounts and fair values of the Senior Credit and 10.625% Senior Notes were as follows:
				Fair values
		Carrying amounts		Level 1		Level 2		Level 3
	Senior Term Loan	$	512,813	$	—	$	528,242	$	—
	10.625% Senior Notes	325,159		—		348,415		—

Description_of_Business_and_Ba3

Description of Business and Basis of Presentation (Details) (USD $)	Jun. 06, 2012	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2012	Jun. 06, 2012	Jun. 06, 2012	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013
In Millions, unless otherwise specified	Thomson Reuters (Healthcare) Inc. (TRHI)	Cost of Revenues	Cost of Revenues	Selling and Marketing Expense	Selling and Marketing Expense	Predecessor	Predecessor	Senior Notes	Senior Notes	Senior Notes
						Cost of Revenues	Selling and Marketing Expense	Senior Note due 2020	Senior Note due 2020	Bank of New York Mellon Trust Company, N.A.
										Senior Note due 2020
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'	'
Percentage of equity interests acquired by Wolverine	100.00%	'	'	'	'	'	'	'	'	'
Prior period reclassified facilities costs	'	$2	$2.50	$0.20	$0.30	$3.30	$0.40	'	'	'
Stated interest rate on Senior Notes ( in percent)	'	'	'	'	'	'	'	10.63%	10.63%	10.63%

Description_of_Business_and_Ba4

Description of Business and Basis of Presentation Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Revenues, net	$123,594	$100,950	$124,263	$363,481
Comprehensive income (loss)	'	'	'	'
Total operating costs and expenses	-120,122	-112,658	-168,613	-367,126
Operating income (loss)	3,472	-11,708	-44,350	-3,645
Income (loss) before income taxes	-13,208	-31,139	-68,796	-58,870
Benefit from income taxes	4,865	11,054	22,685	21,902
Net loss	-8,343	-20,085	-46,111	-36,968
Total comprehensive loss	-8,360	-20,085	-46,111	-36,987
Cash flow	'	'	'	'
Net cash used in operating activities	'	'	-6,639	1,151
Net cash used in investing activities	'	'	-1,260,326	-34,853
As Reported	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Revenues, net	'	104,865	127,695	'
Comprehensive income (loss)	'	'	'	'
Total operating costs and expenses	'	-113,429	-168,161	'
Operating income (loss)	'	-8,564	-40,466	'
Income (loss) before income taxes	'	-27,995	-64,912	'
Benefit from income taxes	'	9,932	21,299	'
Net loss	'	-18,063	-43,613	'
Total comprehensive loss	'	-18,063	-43,613	'
Cash flow	'	'	'	'
Net cash used in operating activities	'	'	-1,609	'
Net cash used in investing activities	'	'	-1,264,825	'
Adjustments	'	'	'	'
Condensed Financial Statements, Captions [Line Items]	'	'	'	'
Revenues, net	'	-3,915	-3,432	'
Comprehensive income (loss)	'	'	'	'
Total operating costs and expenses	'	771	-452	'
Operating income (loss)	'	-3,144	-3,884	'
Income (loss) before income taxes	'	-3,144	-3,884	'
Benefit from income taxes	'	1,122	1,386	'
Net loss	'	-2,022	-2,498	'
Total comprehensive loss	'	-2,022	-2,498	'
Cash flow	'	'	'	'
Net cash used in operating activities	'	'	-5,030	'
Net cash used in investing activities	'	'	$4,499	'

Acquisition_Details

Acquisition (Details) (USD $)	0 Months Ended	6 Months Ended	9 Months Ended
	Jun. 06, 2012	Sep. 30, 2012	Sep. 30, 2013
Business Acquisition [Line Items]	'	'	'
Net cash consideration	'	$1,249,402,000	$0
Common equity contributed	464,400,000	'	1,950,000
Thomson Reuters (Healthcare) Inc. (TRHI)	'	'	'
Business Acquisition [Line Items]	'	'	'
Net cash consideration	1,249,402,000	'	'
Direct costs associated with business acquisition	26,734,000	'	'
Adjustment to goodwill due to purchases	533,000	'	'
Finalization of acquisition valuation adjustment, current assets	458,000	'	'
Finalization of acquisition valuation adjustment, non-current assets	120,000	'	'
Finalization of acquisition valuation adjustment, noncurrent deferred tax liabilities	45,000	'	'
Term Loan	'	'	'
Business Acquisition [Line Items]	'	'	'
Term loan facility principal amount	527,625,000	'	'
Senior Notes	'	'	'
Business Acquisition [Line Items]	'	'	'
Term loan facility principal amount	$327,150,000	'	'

Acquisition_Summary_of_The_Fin

Acquisition Summary of The Final Allocation of Purchase Price (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Jun. 06, 2012
In Thousands, unless otherwise specified			Thomson Reuters (Healthcare) Inc. (TRHI)
Business Acquisition [Line Items]	'	'	'
Trade and other receivables	'	'	$77,598
Prepaid assets and other current assets	'	'	11,973
Computer hardware and other property	'	'	24,693
Developed technology and content	'	'	159,622
Other identifiable intangible assets	'	'	416,000
Other noncurrent assets	'	'	106
Current deferred tax assets	'	'	11,262
Current liabilities	'	'	-46,588
Deferred revenue	'	'	-80,239
Noncurrent deferred tax liabilities	'	'	-149,364
Net assets acquired	'	'	425,063
Goodwill in acquisition	824,339	824,339	824,339
Net consideration paid in cash	'	'	$1,249,402

Acquisition_Pro_Forma_Details

Acquisition Pro Forma (Details) (Thomson Reuters (Healthcare) Inc. (TRHI), USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2012	Sep. 30, 2012
Thomson Reuters (Healthcare) Inc. (TRHI)	'	'
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]	'	'
Revenues, net	$122,630	$361,785
Net loss	($1,277)	($17,444)

Longterm_Debt_Details

Long-term Debt (Details) (USD $)

6 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

Sep. 30, 2012

Sep. 30, 2013

Apr. 26, 2013

Oct. 03, 2012

Sep. 30, 2013

Mar. 04, 2013

Jul. 31, 2013

Sep. 30, 2013

Jun. 06, 2012

Apr. 26, 2013

Sep. 30, 2013

Sep. 30, 2013

Jun. 06, 2012

Apr. 26, 2013

Apr. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Apr. 24, 2013

Dec. 31, 2012

Apr. 26, 2013

Sep. 30, 2013

Jun. 06, 2012

Sep. 30, 2013

Dec. 31, 2012

Apr. 26, 2013

Apr. 26, 2013

Apr. 26, 2013

Apr. 26, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Note due 2020

Senior Note due 2020

Senior Notes, Series B Due 2020

Senior Notes, Series A Due 2020

Senior Notes, Series A Due 2020

Revolving Credit Facility

Revolving Credit Facility

Letter of Credit

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Line of Credit

Line of Credit

Senior Notes

Senior Notes

Senior Notes

Prime Rate

Federal Funds Purchased

One Month Eurodollar

Eurodollar

Bank of New York Mellon Trust Company, N.A.

Prior to June 1, 2016

On or after June 1, 2016

One or after June 1, 2018

Prior to June 1, 2015

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Secured Debt

Secured Debt

Secured Debt

Secured Debt

Secured Debt

Secured Debt

Revolving Credit Facility

Revolving Credit Facility

Senior Note due 2020

Senior Note due 2020

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Notes

Senior Notes

Senior Notes

Senior Notes

Senior Notes

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Credit Facility Due 2019

Senior Note due 2020

Senior Note due 2020

Senior Note due 2020

Senior Note due 2020

Senior Note due 2020

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Senior credit facility maximum borrowing capacity

'

'

$585,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Term loan facility principal amount

'

'

'

'

'

'

327,150,000

'

327,150,000

'

'

'

527,625,000

535,000,000

'

'

'

523,668,000

'

'

'

327,150,000

'

'

'

'

'

'

'

'

'

'

'

Credit Facility maturity term

'

'

'

'

'

'

'

'

'

'

'

'

'

'7 years

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding letters of credit

'

'

'

'

'

'

'

'

'

'

'

300,000

'

'

'

'

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility remaining borrowing capacity

'

'

'

'

'

'

'

'

'

'

34,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Prime rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'prime rate

'federal funds

'one month Eurodollar rate

'Eurodollar

'

'

'

'

'

Basis spread on variable rate (in percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

1.00%

'

'

'

'

'

'

Minimum base rate (in percent)

'

'

2.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Minimum Eurodollar base rate (in percent)

'

'

1.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility commitment fee on unused capacity (in percent)

'

'

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Quarterly payments

'

'

'

'

'

'

'

'

'

'

'

'

'

1,300,000

1,337,500

1,319,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Frequency of periodic payment

'

'

'

'

'

'

'

'

'

'

'

'

'

'quarterly

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduction of the applicable margin from refinancing (in percent)

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

1.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repricing call protection (in percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss on extinguishment of debt

0

2,353,000

'

'

'

'

'

'

'

'

'

'

'

3,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lenders fees associated with refinancing

'

'

'

'

'

'

'

'

'

'

'

'

'

6,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument original issue discount

'

'

'

'

'

'

'

'

'

'

'

'

'

5,800,000

'

'

14,810,000

'

12,174,000

'

'

'

1,790,000

1,991,000

'

'

'

'

'

'

'

'

'

Third party legal costs

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt extinguished costs

'

'

'

'

'

'

'

'

'

'

'

'

'

900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stated interest rate on Senior Notes ( in percent)

'

'

'

'

'

'

10.63%

10.63%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.63%

10.63%

'

'

'

'

10.63%

'

'

'

'

Percentage of redemption price on Notes (in percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

101.00%

'

'

'

'

'

'

100.00%

105.31%

100.00%

110.63%

Maximum redemption percentage of aggregate principal amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35.00%

Additional penalty interest per annum for the 90 day period (in percent)

'

'

'

'

'

0.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional penalty interest per annum for each subsequent 90 day period (in percent)

'

'

'

'

'

0.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum additional penalty interest per annum (in percent)

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional penalty interest incurred and accrued

'

'

'

'

318,100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional penalty interest paid

'

'

'

'

$197,600

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Schedule_of_Longterm_Debt_Deta

Schedule of Long-term Debt (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'	'
Current portion of long-term debt	$5,350	$5,276
Long-term debt excluding current maturities	852,525	832,696
Long-term debt	857,875	837,972
Senior Credit Facility Due 2019 | Secured Debt | Term Loan	'	'
Debt Instrument [Line Items]	'	'
Long-term debt	517,515	512,813
Senior Credit Facility Due 2019 | Revolving Credit Facility | Line of Credit	'	'
Debt Instrument [Line Items]	'	'
Long-term debt	15,000	0
Senior Note due 2020 | Senior Notes	'	'
Debt Instrument [Line Items]	'	'
Long-term debt	$325,360	$325,159

Maturities_of_Longterm_Debt_De

Maturities of Long-term Debt (Details) (USD $)	Sep. 30, 2013
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]	'
2014	$5,350
2015	5,350
2016	5,350
2017	5,350
2018	5,350
Thereafter	825,775
Total long-term debt maturities	$852,525

Longterm_Debt_Parenthetical_De

Long-term Debt Parenthetical (Details) (USD $)	Sep. 30, 2013	Apr. 26, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Senior Notes | Senior Note due 2020	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument original issue discount	$1,790	'	$1,991
Secured Debt | Term Loan | Senior Credit Facility Due 2019	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument original issue discount	$14,810	$5,800	$12,174

Other_Operating_Expenses_Detai

Other Operating Expenses (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended	0 Months Ended		6 Months Ended	5 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Mar. 31, 2012	Mar. 31, 2012	Sep. 30, 2012	Jun. 06, 2012
					Minimum	Maximum	Predecessor	Predecessor
Components of Other Operating Expenses [Line Items]	'	'	'	'	'	'	'	'
Disposal related costs	'	'	$0	$0	'	'	'	$9,818,000
Severance and retention bonuses	348,000	7,592,000	9,704,000	3,147,000	'	'	'	7,741,000
Acquisition related costs	7,289,000	2,448,000	29,879,000	23,683,000	'	'	'	0
Other	641,000	625,000	833,000	1,948,000	'	'	'	1,244,000
Total other operating expenses	8,278,000	10,665,000	40,416,000	28,778,000	'	'	'	18,803,000
Contingent payment period	'	'	'	'	'90 days	'1 year	'	'
Acquisition costs, data center migration and infrastructure	4,700,000	'	'	10,800,000	'	'	'	'
Acquisition costs, transitional services agreement	1,100,000	'	'	9,300,000	'	'	'	'
Acquisition costs, consulting and other professional services	1,500,000	'	'	3,600,000	'	'	'	'
Acquisition costs, professional and marketing fees	'	2,000,000	'	'	'	'	'	'
Acquisition costs, disentanglement costs	'	400,000	400,000	'	'	'	'	'
Acquisition costs, transaction fees	'	'	12,000,000	'	'	'	'	'
Acquisition costs, finance fees	'	'	17,500,000	'	'	'	'	'
Retention and bonus expense against Additional Paid-in Capital	$0	$6,000,000	$8,100,000	$1,378,000	'	'	$5,800,000	'

Segment_Information_Details

Segment Information (Details) (USD $)

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

5 Months Ended

In Thousands, unless otherwise specified

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Jun. 06, 2012

Jun. 06, 2012

Jun. 06, 2012

Jun. 06, 2012

Jun. 06, 2012

Jun. 06, 2012

Jun. 06, 2012

Segment

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Center, Other

Center, Other

Center, Other

Center, Other

Reportable Segments

Reportable Segments

Reportable Segments

Reportable Segments

Predecessor

Predecessor

Predecessor

Predecessor

Predecessor

Predecessor

Predecessor

Payer

Payer

Payer

Payer

Hospitals

Hospitals

Hospitals

Hospitals

Clinicians

Clinicians

Clinicians

Clinicians

Operating Segments

Operating Segments

Operating Segments

Operating Segments

Center, Other

Reportable Segments

Payer

Hospitals

Clinicians

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of reportable segments

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

$123,594

$100,950

$124,263

$363,481

$65,286

$57,625

$70,864

$189,904

$31,138

$24,642

$31,187

$92,492

$27,170

$18,683

$22,212

$81,085

$0

[1]

$0

[1]

$0

[1]

$0

[1]

$123,594

$100,950

$124,263

$363,481

'

$208,995

$106,482

$53,236

$49,277

$3

[1]

$208,998

Depreciation and Amortization(1)

'

'

'

'

13,650

[2]

8,917

[2]

11,180

[2]

38,083

[2]

6,819

[2]

4,415

[2]

5,536

[2]

19,161

[2]

3,885

[2]

2,555

[2]

3,203

[2]

11,024

[2]

2,946

[2]

1,947

[2]

2,441

[2]

7,898

[2]

0

[1],[2]

0

[1],[2]

0

[1],[2]

0

[1],[2]

13,650

[2]

8,917

[2]

11,180

[2]

38,083

[2]

'

19,265

[2]

9,539

[2]

5,520

[2]

4,206

[2]

0

[1],[2]

19,265

[2]

Segment Operating Income (Expense)

$3,472

($11,708)

($44,350)

($3,645)

$20,279

$9,104

$10,214

$59,439

$8,824

$8,292

$9,871

$24,366

$4,019

$480

$673

$12,535

$7,436

$332

($330)

$22,538

$86

[1]

($1,533)

[1]

($3,236)

[1]

($8,461)

[1]

$20,365

$7,571

$6,978

$50,978

($12,439)

$37,980

$15,411

$8,222

$14,347

($23,390)

[1]

$14,590

[1]

Center/Other costs consist of items that are not directly attributable to reportable segments, such as marketing, technical support, executive, administrative costs and allocations from the Predecessor Parent. Center/Other includes the elimination of intercompany transactions.

[2]

Depreciation and amortization expense includes the depreciation of hardware and other tangible assets and the amortization of developed technology and content, but excludes the amortization of other identifiable intangible assets because the CODM during both the Predecessor and Successor Periods did not consider this item when allocating resources and assessing performance.

Segment_Information_Reconcilia

Segment Information Reconciliation to Net Income (Loss) (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended	5 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Jun. 06, 2012	Jun. 06, 2012
					Reportable Segments	Reportable Segments	Reportable Segments	Reportable Segments	Predecessor	Predecessor
										Reportable Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'	'	'	'	'	'	'
Segment operating income (loss)	$3,472	($11,708)	($44,350)	($3,645)	$20,365	$7,571	$6,978	$50,978	($12,439)	$14,590
Amortization of other identifiable intangible assets	-8,615	-8,614	-10,912	-25,845	'	'	'	'	-8,226	'
Interest income	0	0	0	0	'	'	'	'	3	'
Other operating expenses	-8,278	-10,665	-40,416	-28,778	'	'	'	'	-18,803	'
Interest Expense	-16,661	-19,431	-24,446	-54,753	'	'	'	'	0	'
Unrealized foreign exchange loss	-19	0	0	-472	'	'	'	'	0	'
Loss before income taxes	($13,208)	($31,139)	($68,796)	($58,870)	'	'	'	'	($12,436)	'

Sharebased_Compensation_Detail

Share-based Compensation (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended		1 Months Ended	3 Months Ended		9 Months Ended	2 Months Ended	5 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Jun. 30, 2012	Oct. 31, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Jun. 06, 2012	Jun. 06, 2012
					plan	Class B Membership Interest	Class B Membership Interest	Class B Membership Interest	Class B Membership Interest	Predecessor	Predecessor
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Share-based compensation expense	$371,000	$0	$0	$1,137,000	'	'	'	'	'	$1,870,000	$2,519,000
Period in which employees can exercise the options	'	'	'	'	'	'	'	'	'	'6 months	'
Number of options exercised (in shares)	'	'	'	'	'	'	'	'	'	0	'
Number of share-based payment plan related to the plans administered by our Predecessor	'	'	'	'	0	'	'	'	'	'	'
Maximum percentage of Membership Interest can be awarded to executive officers	'	'	'	'	'	6.25%	'	'	'	'	'
Vesting percentage on each of the first five anniversaries (in percent)	'	'	'	'	'	20.00%	'	'	'	'	'
Award vesting period (in years)	'	'	'	'	'	'5 years	'	'	'	'	'
Compensation expense recognized against additional paid in capital	'	'	'	1,137,000	'	'	'	371,000	1,137,000	'	'
Estimated forfeiture rate (in percent)	'	'	'	10.00%	'	'	10.00%	'	'	'	'
Period in which Class B Membership Interest expected to be recognized (in years)	'	'	'	'	'	'	'	'	'4 years 6 months	'	'
Total unrecognized compensation costs	'	'	'	'	'	'	4,116,000	'	4,116,000	'	'
Percent of Class B Membership Interest vested	'	'	'	'	'	'	0.80%	'	0.80%	'	'
Class B Membership Interest vested estimated fair value	'	'	'	'	'	'	'	'	$1,185,000	'	'

Sharebased_Compensation_Transa

Share-based Compensation Transaction Related to Class B Membership Interest (Details) (Class B Membership Interest, USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
Class B Membership Interest	'
Ownership Interests	'
Ownership interest percent, beginning period	4.10%
Ownership interest percent, granted	0.60%
Ownership interest percent, forfeited	-0.40%
Ownership interest percent, ending period	4.30%
Ownership interest percent, outstanding and vested	0.80%
Membership Interest, Fair Value at Grant Date	'
Membership interest fair value at grant date, beginning period	$5,714
Membership interest fair value at grant date, granted	867
Membership interest fair value at grant date, forfeited	-502
Membership interest fair value at grant date, ending period	6,079
Membership interest fair value at grant date, outstanding and vested	$1,143

Related_Party_Cost_Allocations

Related Party Cost Allocations (Details) (Predecessor, Thomson Reuters, USD $)	2 Months Ended	5 Months Ended
In Thousands, unless otherwise specified	Jun. 06, 2012	Jun. 06, 2012
Predecessor | Thomson Reuters	'	'
Related Party Transaction [Line Items]	'	'
Cost of revenues, excluding depreciation and amortization	$2,254	$4,868
Allocation of costs from Predecessor Parent and affiliates	2,550	10,003
Total related party expenses	$4,804	$14,871

Related_Party_Transactions_Nar

Related Party Transactions Narrative (Details) (USD $)

0 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

Jun. 06, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Sep. 30, 2013

Jun. 06, 2012

Thomson Reuters

Thomson Reuters

Thomson Reuters

Thomson Reuters

Thomson Reuters

Thomson Reuters U.S. Inc

Thomson Reuters U.S. Inc

Thomson Reuters U.S. Inc

Thomson Reuters U.S. Inc

Truven Holding Corp.

Minimum

Maximum

Predecessor

Transitional Service Agreement

Transitional Service Agreement

Transitional Service Agreement

Transitional Service Agreement

Reverse Transitional Services Agreement

Reverse Transitional Services Agreement

Reverse Transitional Services Agreement

Reverse Transitional Services Agreement

Thomson Reuters U.S. Inc

Thomson Reuters U.S. Inc

Thomson Reuters Applications, Inc

Reverse Transitional Services Agreement

Reverse Transitional Services Agreement

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Consideration for fixed assets transferred

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$15,975,000

Minimum annual advisory fee payment to Sponsor

'

'

'

'

'

2,500,000

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of consolidated EBITDA for advisory fee calculation (in percent)

'

'

'

'

'

2.00%

'

'

'

'

'

'

'

'

'

'

'

'

Sponsor advisory fees

'

600,000

600,000

800,000

1,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition related costs in other operating expenses

'

'

'

'

'

'

600,000

5,300,000

6,700,000

9,900,000

'

'

'

'

'

'

'

'

Service periods covered in reverse transitional services agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'22 months

'

Income from service agreement reported as a reduction to General and administrative expense

'

'

'

'

'

'

'

'

'

'

100,000

200,000

300,000

600,000

'

'

'

'

Additional capital contribution

$464,400,000

'

'

'

$1,950,000

'

'

'

'

'

'

'

'

'

$1,950,000

'

'

'

Income_Taxes_Details

Income Taxes (Details)	2 Months Ended	3 Months Ended		6 Months Ended	5 Months Ended	9 Months Ended
	Jun. 06, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Jun. 06, 2012	Sep. 30, 2013
Income Tax Contingency [Line Items]	'	'	'	'	'	'
Effective income tax rate (in percent)	'	36.80%	35.50%	33.00%	38.60%	37.20%
Federal statutory tax rate (in percent)	35.00%	35.00%	'	35.00%	'	35.00%

Commitment_and_Contingencies_F

Commitment and Contingencies Future Minimum Lease Payments (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended	5 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2013	Jun. 06, 2012
					Predecessor
Operating Leases, Future Minimum Payments Due, Rolling Maturity [Abstract]	'	'	'	'	'
2014	$10,002,000	'	'	$10,002,000	'
2015	9,778,000	'	'	9,778,000	'
2016	9,054,000	'	'	9,054,000	'
2017	5,896,000	'	'	5,896,000	'
2018	4,091,000	'	'	4,091,000	'
Thereafter	7,923,000	'	'	7,923,000	'
Total future minimum lease payments	46,744,000	'	'	46,744,000	'
Rent expense	$3,100,000	$2,600,000	$3,300,000	$8,500,000	$4,200,000

Commitment_and_Contingencies_C

Commitment and Contingencies Capital Leases (Details) (USD $)	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Capital lease of computer hardware and other property net book value	$1,500,000
Capital lease of computer hardware and other property accumulated depreciation	300,000
Capital lease future minimum lease payment within one year	972,000
Present value of capital lease net minimum payments	$946,000

Commitment_and_Contingencies_C1

Commitment and Contingencies Commitment and Contingencies (Details) (USD $)	9 Months Ended			0 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Jan. 03, 2013	Sep. 30, 2013	Jan. 02, 2013
	Motion		Reglan Case	Revenue Share with Supplier	Revenue Share with Supplier	Minimum
			Claim			Revenue Share with Supplier
Long-term Purchase Commitment [Line Items]	'	'	'	'	'	'
Revenue share arrangement term with a supplier	'	'	'	'1 year	'	'
Revenue share minimum amount guaranteed by the Company in 2013	'	'	'	'	'	$2,000,000
Revenue share minimum amount guaranteed by the Company in 2014	'	'	'	'	'	4,000,000
Revenue share minimum amount guaranteed by the Company in 2015	'	'	'	'	'	6,000,000
Remaining balance of prepaid revenue share	$22,862,000	$18,409,000	'	'	$2,000,000	'
Number of pharmaceutical tort lawsuits	'	'	225	'	'	'
Number of dispositive motion to dismiss all the actions	1	'	'	'	'	'

Fair_Value_Measurement_Details

Fair Value Measurement (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Senior Notes, Series A Due 2020	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Stated interest rate on Senior Notes ( in percent)	10.63%	'
Senior Note due 2020 | Senior Notes	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Stated interest rate on Senior Notes ( in percent)	10.63%	10.63%
Fair Value, Inputs, Level 1 | Senior Credit Facility Due 2019 | Term Loan | Secured Debt	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	0	0
Fair Value, Inputs, Level 1 | Senior Credit Facility Due 2019 | Line of Credit | Revolving Credit Facility	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	0	'
Fair Value, Inputs, Level 1 | Senior Note due 2020 | Senior Notes	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	0	0
Fair Value, Inputs, Level 2 | Senior Credit Facility Due 2019 | Term Loan | Secured Debt	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	533,656	528,242
Fair Value, Inputs, Level 2 | Senior Credit Facility Due 2019 | Line of Credit | Revolving Credit Facility	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	15,000	'
Fair Value, Inputs, Level 2 | Senior Note due 2020 | Senior Notes	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	361,501	348,415
Fair Value, Inputs, Level 3 | Senior Credit Facility Due 2019 | Term Loan | Secured Debt	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	0	0
Fair Value, Inputs, Level 3 | Senior Credit Facility Due 2019 | Line of Credit | Revolving Credit Facility	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	0	'
Fair Value, Inputs, Level 3 | Senior Note due 2020 | Senior Notes	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	0	0
Reported Value Measurement | Senior Credit Facility Due 2019 | Term Loan | Secured Debt	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	517,515	512,813
Reported Value Measurement | Senior Credit Facility Due 2019 | Line of Credit | Revolving Credit Facility	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	15,000	'
Reported Value Measurement | Senior Notes, Series A Due 2020 | Line of Credit | Revolving Credit Facility	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	325,360	'
Reported Value Measurement | Senior Note due 2020 | Senior Notes	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Fair values	'	325,159

Supplemental_Guarantor_Financi1

Supplemental Guarantor Financial Information (Details) (USD $)	Sep. 30, 2013	Jun. 06, 2012
In Thousands, unless otherwise specified	Subsidiary-guarantor	Thomson Reuters (Healthcare) Inc. (TRHI)
Condensed Financial Statements, Captions [Line Items]	'	'
Ownership percentage wholly owned subsidiary	100.00%	'
Number of subsidiary guarantors	0	'
Acquisition related costs	'	$26,734